Saturday, August 18, 2018 11:36:57 PM
Expansion, expansion, expansion. Much of the expansion will be completed by early 2019. Expansion completion, and then in business, will increase revenue.
- TRTC financials in 2019 will increase investor confidence and move PPS substantially.
-- Staggered weekly or bi-weekly harvests (some in Q3, regular ongoing in 2018 Q4 and into 2019)
-- 30,000 sq ft, seeds in ground in NV ALREADY
-- ADDITIONAL 40,000 sq ft cultivation site to be built in NV
-- Reduced costs with seed to sale - no need to buy outsider wholesale
-- New dispensaries complete by Q4 in CA and in NV. Even MORE in 2019
-- Increased extraction
-- Likely CA changes in taxation, home delivery, cracking down on black-market
-- Highly possible changes at federal level in laws, banking, drug schedule. Learn what 280E is and what it will mean when it changes
-- Bi partisan support for federal law changes and drug schedule changes is increasing rapidly now, as meantime more states legalize
-- Nj ready to legalize for recreational use: TRTC well positioned in NJ already
-- New dispensary(s) in NV to replace sold off poorly performing location (Western Ave)
-- Watch for announcements of new locations opening in CA and NV
-- TRTC applying for more licenses than needed in some areas - with eye towards flipping some for profit
-- TRTC entering beverage cannabis market as well
TRTC has NEVER been better positioned. 2019 is payday for smart investors. Expansion = revenue. 2019 will show SLOWED dilution (depending on how aggressive new expansion is in 2019).
Take your risks, and then either take your rewards or take your lumps based on your decision. Just don't be like some people and blame everyone and everything but yourself for your own decisions in life.
2019 will see this investment appreciate --Unlike many other OTC choices that have lost tremendous value.
Retired, non user of MJ but support legalization
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM